Senior Director, Market Access Strategy, International

BridgeBio Pharma; Schweiz; On-site; CHF 180,000 - 270,000; Full time

Benefits offered by this job

Market leading compensation

Hybrid work model

Career development programs

Growth opportunities

Job summary

BridgeBio Pharma, based in Zug, Switzerland, seeks a Senior Director, Market Access Strategy, International to lead pricing and reimbursement across multiple international markets for rare diseases. The role focuses on shaping the value narrative and accelerating patient access from pre-launch to launch phases.

You will partner with HEOR, regional brand teams, and market access heads to drive strategic initiatives, oversee dossiers, and engage with HTA authorities while thriving in a fast-paced,

Qualifications

• Extensive experience leading HTA submissions and pricing negotiations across multiple international markets.
• Strong knowledge of international healthcare systems, pricing and reimbursement frameworks.
• Experience building data-driven value propositions and engaging with external agencies.

Responsibilities

• Represent payer perspective within cross-functional, cross-regional teams to optimize pricing and market access of the asset.
• Collaborate with HEOR, clusters' leadership, Marketing and Clinical Development to ensure value and access optimization.
• Lead early payer engagement with HTA bodies (e.g. NICE UK, G-BA Germany) to inform evidence generation and reimbursement dossiers.
• Interact with pricing, health economics, patient advocacy, HTA authorities, policy makers and payers to execute Pricing & Reimbursement objectives.
• Provide hands-on support and train local access teams on negotiation strategy and ensure submissions align with Global/International strategy.

Skills

HTA submissions

Pricing negotiations

International markets

Rare diseases

Cross-functional leadership

Stakeholder engagement

Job description

Senior Director, Market Access Strategy, International

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early‑stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allowsscience and small teams of experts to lead the way. We build bridges to groundbreaking advancements in raredisease, anddevelop life‑changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'llask"why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

About BridgeBio Pharma, Inc.

BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late‑stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.

Who We Are

BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high‑performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.

At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision‑making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.

You will report to the VP, Head of Market Access, International and work closely with international Market Access, regional brand team, and heads or markets access in BridgeBio clusters as well as with field‑based colleagues across multiple geographies, to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients globally.

Your primary purpose will be to secure timely, sustainable patient access to the company’s products by shaping the value narrative, and leading pricing and reimbursement strategies and execution across multiple international markets. This includes oversight of related dossiers, negotiations, and cost coverage approaches. In this role you ensure alignment of Market Access ambitions with clinical value and global pricing interdependencies.

You will also be a core member of the International Market Access team, contributing to global decision‑making and ensuring alignment across regions while representing diverse market perspectives.

This role requires strong collaboration with cross‑functional colleagues and external stakeholders across multiple countries to ensure high‑quality execution and impact. The ideal candidate combines deep expertise in Market Access processes across several international markets and experience introducing innovative therapies in a global biotech environment. You are eager to make a meaningful contribution in pre‑launch and launch phases, particularly within rare diseases and orphan conditions, and bring strong communication skills, adaptability, and the ability to thrive in a fast‑paced, hands‑on environment.

Responsibilities

• Represent the payer perspective within cross‑functional, cross‑regional commercialization teams thereby optimizing pricing and market access of the asset.
• Closely collaborate with HEOR and clusters' leadership teams, Marketing and Clinical Development counterparts to ensure value and access optimization for the asset.
• Lead early payer engagement with key HTA/payer bodies (e.g. NICE UK, G-BA Germany) to inform evidence generation strategy, value proposition and reimbursement dossiers development.
• Interact with internal and external experts in pricing, health economics, patient advocacy, health technology assessment authorities, government policy makers and payers as required to execute Pricing & Reimbursement objectives.
• Provide hands‑on support and train local access teams on negotiation strategy and ensure HTA and reimbursement submissions are aligned to the Global and International strategy.

Where You’ll Work

This is an office role based and requires in‑office collaboration 2-3x per week in our Zug Office.

Who You Are

• Extensive experience leading HTA submissions and pricing negotiations across multiple international markets, ideally including Europe and other global regions, particularly in rare diseases and orphan conditions.
• Strong knowledge of international healthcare systems, pricing and reimbursement frameworks, and regulatory environments.
• Experience generating and leveraging data for HTA submissions and pricing negotiations, with a strong external network of agencies and stakeholders.
• Comfortable presenting at senior levels and engaging with external thought leaders globally.
• Proven experience managing complex, cross‑functional and multicultural teams (including external partners).
• Knowledge of product commercialization processes with a hands‑on, solution‑oriented mindset for building scalable processes and documentation.

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

• Market leading compensation
• Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
• We provide career development through regular feedback, continuous education and professional development programs
• We celebrate strong performance with financial rewards, peer‑to‑peer recognition, and growth opportunities.

As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

For BridgeBio Full‑Time U.S Based Roles:

• Market‑leading compensation
• 401(k) with employer match
• Employee Stock Purchase Program (ESPP)
• Pre‑tax commuter benefits (transit and parking)
• Referral bonus for hired candidates
• Subsidized lunch and parking on in‑office days
• 100% employer‑paid medical, dental, and vision premiums for you and your dependents
• HealthSavings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA)
• Fertility & family‑forming benefits
• Expanded mental health support (therapy and coaching resources)
• Hybrid work model with flexibility
• Flexible, “take‑what‑you‑need” paid time off and company‑paid holidays
• Comprehensive paid medical and parental leave to care for yourself and your family

Skill Development & Career Paths:

• People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
• We provide career pathing through regular feedback, continuouseducationand professional development programs via LinkedIn Learning,LifeLabs, &BetterUpCoaching
• We celebratestrong performancewith financial rewards, peer‑to‑peer recognition, and growth opportunities